Fundz

Nrg Therapeutics Announces £16 Million Series A To Advance Mitochondrial Therapeutics For Parkinson's And Als

PRIVATENov 09, 2022

Amount Raised

£16 Million

Round Type

Series A

StevenageBiotechnologyHealth CareTherapeutics

Description

NRG Therapeutics, Ltd., an innovative neuroscience company targeting mitochondrial dysfunction, today announced the closing of a £16 million Series A financing, led by Omega Funds and joined by additional new investor Brandon Capital and founding investor the Parkinson's Virtual Biotech. In connection with the financing, Omega Funds Managing Director Claudio Nessi and Partner Francesco Draetta, as well as Brandon Capital Partner Jonathan Tobin, have joined the company's Board of Directors.

Who to call at NRG Therapeutics, and when

A new round usually means NRG Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day NRG Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at NRG Therapeutics, from your own LinkedIn network
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

NRG Therapeutics

Location

Stevenage, England, United Kingdom

About

NRG Therapeutics is a neuroscience drug discovery company building a pipeline of disease-modifying mitochondrial therapeutics to slow or halt the progression of neurodegenerative disorders such as Parkinson's and Amyotrophic Lateral Sclerosis (ALS), also known as motor neurone disease (MND).

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment NRG Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsNeil M., CEO hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for NRG Therapeutics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

NRG Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.